ELICASAL

This brand name is authorized in Nigeria.

Active ingredients

The drug ELICASAL contains a combination of these active pharmaceutical ingredients (APIs):

1	Mometasone UNII 04201GDN4R - MOMETASONE FUROATE
	Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.
	Read more about Mometasone
2	Salicylic acid UNII O414PZ4LPZ - SALICYLIC ACID
	Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium.
	Read more about Salicylic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7660	Ointment	ELICASAL OINTMENT OINTMENT 0.1%; 5% 1x30g	48 RNW-PP-292805 ELICASAL OINTMENT MOMETASONE FUROATE 0.1% W/V, SALICYLIC ACID 5% W/V MOMETASONE FUROATE 0.1%,SALICYLIC ACID 5%W/W B4-7660 Drugs Imported Products 1x30g Prescription Only Medicine (POM) 12/5/2022 ASSENE-LABOREX LIMITED, AMUWO ODOFIN INDUSTRIAL SCHEME LAGOS LAGOS 17769700 esther.amuzie@assene-laborex.com JAMJOOM PHARMA CO.LTD , PLOT NO MEI-3 PHASE V INDUSTRIAL CITY ,JEDDAH, SAUDI-ARABIA, Saudi Arabia	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07XC03	Mometasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XC Corticosteroids, potent, other combinations
Discover more medicines within D07XC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7660